Colorectal Cancer Clinical Trials in Florida

Showing 141-160 of 192 trials

Paired Analysis of Sensitivity for Colorectal Cancer Using COLVERA : PASCAL

NCT03706248

To compare the sensitivity and specificity estimates of Colvera with that of a commercially available CEA test for detection of recurrent disease in subjects with colorectal cancer that have documented recurrence or no evidence of recurrence by CT.

Colorectal Cancer

Clinical Genomics Pathology65 participantsStarted Jul 2018

Redondo Beach, California, United States • Tampa, Florida, United States • Chicago, Illinois, United States +3 more locations

TERMINATEDPhase 249 miles

Study of Ruxolitinib in Colorectal Cancer Patients

NCT02119676

The purpose of this study was to determine if ruxolitinib, in combination with regorafenib, is safe and effective in the treatment of metastatic colorectal cancer.

CRC (Colorectal Cancer)

Incyte Corporation396 participantsStarted Mar 2014

Chandler, Arizona, United States • Gilbert, Arizona, United States • Mesa, Arizona, United States +83 more locations

Paired Analysis of Sensitivity for Colorectal Cancer Using COLVERA : PASCAL

Study of Ruxolitinib in Colorectal Cancer Patients

Colorectal Cancer Trials in Other Cities

A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer

Pre-operative 5-Fluorouracil (5-FU) and Sorafenib With External Radiation in Locally Advanced Rectal Cancer

Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer

A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer

Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer

Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy

Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer

A Study in Second Line Metastatic Colorectal Cancer

A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)

Sym004 vs Standard of Care in Subjects With Metastatic Colorectal Cancer

PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study

Study of Bevacizumab + mFOLFOX6 Versus Bevacizumab + FOLFIRI With Biomarker Stratification in Participants With Previously Untreated Metastatic Colorectal Cancer (mCRC)

FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer

A Phase II Study of the Safety and Efficacy of E7820 Plus Cetuximab in Colorectal Cancer, Preceded by a Run-in Study in Advanced Solid Tumors

Gene Testing in Patients With Colon Cancer

Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX

Vitamin D/Calcium Polyp Prevention Study

Regional Anesthesia in Colon Rectal Surgery

Other Conditions in Florida